Wedbush analyst Laura Chico lowered the firm’s price target on Edgewise Therapeutics (EWTX) to $35 from $40 and keeps an…
Read More »lowered
Truist lowered the firm’s price target on Ultragenyx (RARE) to $100 from $140 and keeps a Buy rating on the…
Read More »River Road Asset Management, an investment management company released its “River Road Small-Mid Cap Value Fund” Q4 2024 investor letter.…
Read More »https://www.tipranks.com/news/the-fly/psq-holdings-price-target-lowered-to-4-from-5-at-roth-mkm Roth MKM lowered the firm’s price target on PSQ Holdings (PSQH) to $4 from $5 and keeps a Buy…
Read More »